Doctor profile · Federal record
Dr. Brian Abittan, M.D.
Dermatology Physician (CMS: Dermatology) · Student in an Organized Health Care Education/Training Program · New York, NY
- NPI 1902284482
- Accepts Medicare
- 11 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
234 E 85Th St Fl 5
New York, NY 100283001
(212) 241-6585 - Mailing address
-
450 Clarkson Ave
Brooklyn, NY 112032098
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- September 2, 2021
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #285104
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902284482. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
841
Distinct HCPCS
10
Medicare allowed
$63,088
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 244 | 130 | $95 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 144 | 54 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 103 | 72 | $55 | |
11102 |
Biopsy of related skin growth, first growth | 94 | 81 | $105 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 49 | 23 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 43 | 40 | $136 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 37 | 37 | $119 | |
11103 |
Biopsy of related skin growth, each additional growth | 32 | 25 | $53 | |
11901 |
Injection into skin growth, more than 7 growths | 28 | 13 | $72 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 24 | 20 | $179 |
In context: peer comparison
Among 139 peers in New York Dermatology Physician, average services per provider: 182. This provider delivers 4.6× the peer median.Open Payments
Industry payments received
All-time total
$42,028
Transactions
179
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 78 | $40,121.51 | |
| Dermavant Sciences, INC. | 18 | $487.68 | |
| E.R. Squibb & Sons, L.L.C. | 25 | $386.44 | |
| Abbvie INC. | 29 | $377.58 | |
| Arcutis Biotherapeutics, INC. | 15 | $182.34 | |
| Pfizer INC. | 5 | $101.92 | |
| Janssen Biotech, INC. | 1 | $99.99 | |
| Regeneron Healthcare Solutions, INC. | 1 | $85.47 | |
| Leo Pharma INC. | 2 | $56.13 | |
| Genzyme Corporation | 2 | $50.13 | |
| Revance Therapeutics, INC. | 1 | $36.88 | |
| Ucb, INC. | 1 | $22.35 | |
| Biofrontera INC. | 1 | $19.76 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
712
Patients
437
Total drug cost
$23,092
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Minoxidil | Generic | 99 | 38 | $1,612 |
| Clobetasol Propionate | Generic | 79 | 46 | $4,169 |
| Ketoconazole | Generic | 75 | 51 | $2,058 |
| Ammonium Lactate | Generic | 69 | 38 | $1,767 |
| Triamcinolone Acetonide | Generic | 58 | 50 | $2,424 |
| Mupirocin | Generic | 53 | 47 | $475 |
| Clindamycin Phosphate | Generic | 48 | 25 | $2,699 |
| Finasteride | Generic | 44 | 13 | $925 |
| Mometasone Furoate | Generic | 35 | 33 | $1,046 |
| Fluocinonide | Generic | 31 | 22 | $1,392 |
Frequently asked questions
What is Dr. Brian Abittan's medical specialty?
Dr. Brian Abittan practices Dermatology Physician in New York, NY.
Where does Dr. Brian Abittan practice?
Dr. Brian Abittan practices at 234 E 85Th St Fl 5, New York, NY 100283001. Office phone: 2122416585.
What is Dr. Brian Abittan's NPI?
Dr. Brian Abittan's National Provider Identifier (NPI) is 1902284482, issued by NPPES.
Does Dr. Brian Abittan accept Medicare assignment?
Yes. Dr. Brian Abittan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brian Abittan commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.